OncoZenge AB (publ) (FRA:8LY)
Germany · Delayed Price · Currency is EUR 0.5310
-0.0140 (-2.57%)
At close: Jan 9, 2026
OncoZenge AB Market Cap
OncoZenge AB has a market cap or net worth of €7.02 million as of January 9, 2026. Its market cap has increased by 77.05% in one year.
Market Cap
7.02M
Enterprise Value
6.64M
Revenue
251.72K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.53
Market Cap Chart
Since February 12, 2021, OncoZenge AB's market cap has decreased from 8.84M to 7.02M, a decrease of -20.57%. That is a compound annual growth rate of -4.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 7.02M | -11.21% |
| Dec 30, 2025 | 7.91M | 106.31% |
| Dec 30, 2024 | 3.83M | 18.06% |
| Dec 29, 2023 | 3.25M | -43.86% |
| Dec 30, 2022 | 5.78M | -56.26% |
| Dec 30, 2021 | 13.22M | 49.56% |
| Feb 12, 2021 | 8.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |